The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Temozolomide (TMZ) maintenance in patients with primary brain cancer treated with postoperative TMZ plus radiotherapy (RT): A retrospective analysis.
Luca Moscetti
No relevant relationships to disclose
Maria Agnese Fabbri
No relevant relationships to disclose
Isabella Sperduti
No relevant relationships to disclose
Giovanni Mansueto
No relevant relationships to disclose
Anna Maria Fariello
No relevant relationships to disclose
Teresa Gamucci
No relevant relationships to disclose
Michle Battista
No relevant relationships to disclose
Massimiliano Loffreda
No relevant relationships to disclose
Luciano Pompei
No relevant relationships to disclose
Enzo Ruggeri
No relevant relationships to disclose